Status:
COMPLETED
Single and Multiple Ascending Doses of AZD1981 in Japan
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects
Eligibility Criteria
Inclusion
- Healthy Japanese and Caucasian males
Exclusion
- Other clinically relevant disease or disorders
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00698282
Start Date
August 1 2008
End Date
October 1 2008
Last Update
December 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Berkshire, United Kingdom